SYRE Operating Expenses
Spyre Therapeutics Inc · Operating Expenses
SYRE Operating Expenses
Latest reported$201.34Mperiod ending
SYRE TTM Operating Expenses ($8.90M → $201.34M)
TTM operating expenses
High-resolution chart · PNG
SYRE operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 201,340,000 | |
| 201,636,000 | |
| 209,562,000 | |
| 168,396,000 | |
| 212,147,000 | |
| 214,359,000 | |
| 208,566,000 | |
| 193,227,000 | |
| 156,172,000 | |
| 271,959,000 | |
| 242,641,000 | |
| 215,567,000 | |
| 215,657,000 | |
| 78,296,000 | |
| 85,146,000 | |
| 89,890,000 | |
| 78,302,000 | |
| 62,551,000 | |
| 55,454,000 | |
| 54,646,000 | |
| 65,930,000 | |
| 80,668,000 | |
| 81,481,000 | |
| 80,614,000 | |
| 84,637,000 | |
| 81,699,000 | |
| 80,334,000 | |
| 73,730,000 | |
| 63,827,000 | |
| 57,253,000 | |
| 49,351,000 | |
| 42,154,000 | |
| 39,170,000 | |
| 35,321,000 | |
| 32,879,000 | |
| 31,561,000 | |
| 29,752,000 | |
| 28,421,000 | |
| 26,534,000 | |
| 25,326,000 | |
| 22,366,000 | |
| 20,357,000 | |
| 17,400,000 | |
| 14,999,000 | |
| 13,649,000 | |
| 10,516,000 | |
| 8,904,000 |